StockData
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31

LABCORP HOLDINGS INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$318.83+0.88 (+0.28%)

Close on Oct 19, 2026

Market cap
$26.14B
P/E (TTM)
26.4
Dividend yield
0.90%

Earnings

Next report expected Oct 27, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 30, 2026Before market open$3.73B$3.64$4.99
Q1 FY2026
Ended Mar 31, 2026
Apr 30, 2026Before market open$3.54B$3.35$4.25
Q4 FY2025
Ended Dec 31, 2025
Feb 17, 2026Before market open$3.52B$1.98$4.07
Q3 FY2025
Ended Sep 30, 2025
Oct 28, 2025Before market open$3.56B$3.12$4.18
Q2 FY2025
Ended Jun 30, 2025
Jul 24, 2025Before market open$3.53B$2.84$4.35
Q1 FY2025
Ended Mar 31, 2025
Apr 29, 2025Before market open$3.35B$2.52$3.84
Q4 FY2024
Ended Dec 31, 2024
Feb 6, 2025Before market open$3.33B$1.70$3.45
Q3 FY2024
Ended Sep 30, 2024
Oct 24, 2024Before market open$3.28B$2.00$3.50
Q2 FY2024
Ended Jun 30, 2024
Aug 1, 2024Before market open$3.22B$2.43$3.94
Q1 FY2024
Ended Mar 31, 2024
Apr 25, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 15, 2024Before market open–––

Company guidance

Outlook given with results on Jul 30, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted EPSnon-GAAP2026$18.10 to $18.55Raised
Free Cash Flownon-GAAP2026$1.24B to $1.36BMaintained
Growth20265.4% to 6.3% growthRaised
Diagnostics Laboratories Growth20265.3% to 6% growthLowered
Biopharma Laboratory Services Growth20265.5% to 6.5% growthRaised
Labcorp Enterprise2026$14.71B to $14.83BRaised
Diagnostics Laboratories2026$11.45B to $11.53BLowered
Biopharma Laboratory Services2026$3.27B to $3.30BLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Labcorp filed with the SEC